| scholarly article | Q13442814 |
| P50 | author | Vara Prasad Manchem | Q114735213 |
| Shin Yonemitsu | Q114735219 | ||
| Gerald I. Shulman | Q52509909 | ||
| Yoshio Nagai | Q56872609 | ||
| Matthew P Gillum | Q58105969 | ||
| Jennifer L Hsiao | Q80108091 | ||
| Gary W Cline | Q88551066 | ||
| Daniel F Vatner | Q90437843 | ||
| Sanjay Bhanot | Q91594238 | ||
| Varman T Samuel | Q92904946 | ||
| Jianying Dong | Q114419326 | ||
| Mario Kahn | Q114735206 | ||
| P2093 | author name string | Derek M Erion | |
| Susan F Murray | |||
| Kisha Mitchell | |||
| Violetta Popov | |||
| P2860 | cites work | A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 |
| Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity | Q28253424 | ||
| ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome | Q28280671 | ||
| Fructose induced lipogenesis: from sugar to fat to insulin resistance | Q28298033 | ||
| Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content | Q28344923 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis | Q28508851 | ||
| A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism | Q28513195 | ||
| Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease | Q28571421 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice | Q33852162 | ||
| Diacylglycerol-mediated insulin resistance | Q34109119 | ||
| Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver | Q34532657 | ||
| A dual sugar challenge test for lipogenic sensitivity to dietary fructose | Q34617112 | ||
| Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes | Q34991322 | ||
| The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | Q35090215 | ||
| Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease | Q35239565 | ||
| Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis | Q36557194 | ||
| Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism | Q37156313 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats | Q37237016 | ||
| Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. | Q38311106 | ||
| Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. | Q38313248 | ||
| Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism | Q38325784 | ||
| Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein | Q38348521 | ||
| Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). | Q39716403 | ||
| Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus | Q43267910 | ||
| Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c | Q43848640 | ||
| Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha | Q43948724 | ||
| Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. | Q44493753 | ||
| CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans | Q44499486 | ||
| Stimulation of glucose phosphorylation by fructose in isolated rat hepatocytes | Q45888261 | ||
| Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy | Q46779898 | ||
| ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver | Q50336015 | ||
| Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver | Q61203329 | ||
| Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice | Q70455207 | ||
| In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated | Q71219991 | ||
| Assay of the deuterium enrichment of water via acetylene | Q71516211 | ||
| Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques | Q73013685 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 36-44 | |
| P577 | publication date | 2012-11-16 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | The role of the carbohydrate response element-binding protein in male fructose-fed rats | |
| P478 | volume | 154 |
| Q34473275 | A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults |
| Q28289130 | Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies |
| Q50936974 | ChREBP refines the hepatic response to fructose to protect the liver from injury. |
| Q37395843 | ChREBP regulates fructose-induced glucose production independently of insulin signaling |
| Q40656080 | Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats |
| Q55050296 | Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. |
| Q94571532 | Fructose Feeding and Hyperuricemia: a Systematic Review and Meta-Analysis |
| Q49498180 | Fructose metabolism and metabolic disease |
| Q34370884 | Fructose, pregnancy and later life impacts |
| Q89828866 | Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia |
| Q64259260 | Impaired Skeletal Muscle Branched-Chain Amino Acids Catabolism Contributes to Their Increased Circulating Levels in a Non-Obese Insulin-Resistant Fructose-Fed Rat Model |
| Q47553435 | Interplay between ChREBP and SREBP-1c Coordinates Postprandial Glycolysis and Lipogenesis in Livers of Mice |
| Q47268980 | Intestinal, but not hepatic, ChREBP is required for fructose tolerance. |
| Q38702671 | LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice |
| Q35130458 | Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis |
| Q51750836 | Liver and Metformin: Lessons of a fructose diet in mice. |
| Q47779219 | Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases |
| Q34037052 | Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis |
| Q38115711 | Passive fructose transporters in disease: a molecular overview of their structural specificity |
| Q26820876 | Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux |
| Q41565910 | Retinol saturase coordinates liver metabolism by regulating ChREBP activity. |
| Q24562080 | Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler |
| Q45071780 | Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis |
| Q30249128 | The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis |
| Q35040509 | The good, the bad, and the unknown: Fructose and FGF21 |
| Q36430696 | The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux |
| Q27016052 | The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease |
| Q26752583 | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight |
Search more.